NCT02996110 A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT02966548 Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02935634 A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT02750514 An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT02488759 An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01968109 An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors Status COMPLETED Phase PHASE1/PHASE2